Tags

Type your tag names separated by a space and hit enter

Meeting targets in type 2 diabetes care contributing to good glycaemic control. A cross-sectional study from a primary care setting in Estonia.
Eur J Gen Pract. 2010 Jun; 16(2):85-91.EJ

Abstract

OBJECTIVE

To assess glycaemic control among Estonian patients with type 2 diabetes mellitus (DM2) and to find patient and disease related factors associated with adequate glycaemic control.

METHODS

A cross-sectional study of 200 randomly selected DM2 patients from a primary care setting. Data on each patient's glycosylated haemoglobin (HbA1c), body mass index, blood pressure, and medications for treatment of DM2 were provided by family doctors. A structured patient questionnaire was administered as a telephone interview (n = 166). The patients' self-management behaviour, awareness of the HbA1c test and its recent value were inquired.

RESULTS

The mean HbA1c of the DM2 patients was 7.5%. The targets of DM2 treatment were achieved as follows: 39% of the patients had HbA1c below 6.5% and half the patients had HbA1c below 7%. More than third of the patients had systolic blood pressure below 140 mmHg and in 51% of the patients diastolic blood pressure was below 85 mmHg. Six per cent of the patients were in normal weight (<25 kg/m(2)). Fifty-two per cent of the patients were aware of the HbA1c test and 36% of them knew its recent value. In multivariate regression analysis, awareness of the HbA1c test but not the HbA1c value, longer duration of diabetes and not having a self-monitoring device were independently associated with adequate glycaemic control (HbA1c< 6.5%).

CONCLUSION

The studied DM2 patients often did not reach the clinical targets suggested in the guidelines. Awareness of the HbA1c test was related to better glycaemic control. However, advanced stage of the disease had a negative effect on HbA1c.

Links

Publisher Full Text

Authors+Show Affiliations

Rätsep A
Department of Family Medicine, University of Tartu, Estonia. anneli.ratsep@ut.ee
Kalda R
No affiliation info available
Lember M
No affiliation info available

MeSH

AgedBlood GlucoseBlood Glucose Self-MonitoringBlood PressureBody Mass IndexCross-Sectional StudiesDiabetes Mellitus, Type 2EstoniaFemaleGlycated Hemoglobin AHealth Knowledge, Attitudes, PracticeHumansHypoglycemic AgentsMaleMiddle AgedMultivariate AnalysisPrimary Health CareRegression AnalysisRisk FactorsSelf CareSurveys and QuestionnairesTime Factors

Pub Type(s)

Journal Article
Research Support, Non-U.S. Gov't

Language

eng

PubMed ID

20429704

Citation

Rätsep, Anneli, et al. "Meeting Targets in Type 2 Diabetes Care Contributing to Good Glycaemic Control. a Cross-sectional Study From a Primary Care Setting in Estonia." The European Journal of General Practice, vol. 16, no. 2, 2010, pp. 85-91.
Rätsep A, Kalda R, Lember M. Meeting targets in type 2 diabetes care contributing to good glycaemic control. A cross-sectional study from a primary care setting in Estonia. Eur J Gen Pract. 2010;16(2):85-91.
Rätsep, A., Kalda, R., & Lember, M. (2010). Meeting targets in type 2 diabetes care contributing to good glycaemic control. A cross-sectional study from a primary care setting in Estonia. The European Journal of General Practice, 16(2), 85-91. https://doi.org/10.3109/13814788.2010.481017
Rätsep A, Kalda R, Lember M. Meeting Targets in Type 2 Diabetes Care Contributing to Good Glycaemic Control. a Cross-sectional Study From a Primary Care Setting in Estonia. Eur J Gen Pract. 2010;16(2):85-91. PubMed PMID: 20429704.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Meeting targets in type 2 diabetes care contributing to good glycaemic control. A cross-sectional study from a primary care setting in Estonia. AU - Rätsep,Anneli, AU - Kalda,Ruth, AU - Lember,Margus, PY - 2010/5/1/entrez PY - 2010/5/1/pubmed PY - 2010/9/10/medline SP - 85 EP - 91 JF - The European journal of general practice JO - Eur J Gen Pract VL - 16 IS - 2 N2 - OBJECTIVE: To assess glycaemic control among Estonian patients with type 2 diabetes mellitus (DM2) and to find patient and disease related factors associated with adequate glycaemic control. METHODS: A cross-sectional study of 200 randomly selected DM2 patients from a primary care setting. Data on each patient's glycosylated haemoglobin (HbA1c), body mass index, blood pressure, and medications for treatment of DM2 were provided by family doctors. A structured patient questionnaire was administered as a telephone interview (n = 166). The patients' self-management behaviour, awareness of the HbA1c test and its recent value were inquired. RESULTS: The mean HbA1c of the DM2 patients was 7.5%. The targets of DM2 treatment were achieved as follows: 39% of the patients had HbA1c below 6.5% and half the patients had HbA1c below 7%. More than third of the patients had systolic blood pressure below 140 mmHg and in 51% of the patients diastolic blood pressure was below 85 mmHg. Six per cent of the patients were in normal weight (<25 kg/m(2)). Fifty-two per cent of the patients were aware of the HbA1c test and 36% of them knew its recent value. In multivariate regression analysis, awareness of the HbA1c test but not the HbA1c value, longer duration of diabetes and not having a self-monitoring device were independently associated with adequate glycaemic control (HbA1c< 6.5%). CONCLUSION: The studied DM2 patients often did not reach the clinical targets suggested in the guidelines. Awareness of the HbA1c test was related to better glycaemic control. However, advanced stage of the disease had a negative effect on HbA1c. SN - 1751-1402 UR - https://www.unboundmedicine.com/medline/citation/20429704/Meeting_targets_in_type_2_diabetes_care_contributing_to_good_glycaemic_control__A_cross_sectional_study_from_a_primary_care_setting_in_Estonia_ L2 - https://www.tandfonline.com/doi/full/10.3109/13814788.2010.481017 DB - PRIME DP - Unbound Medicine ER -